What is the most sensitive diagnostic test sequence to co...

Thank you for reaching out about this Boston Terrier. Her clinical presentation — progressive alopecia, a pendulous abdomen, marked PU/PD, and an elevated alkaline phosphatase (ALP) — is highly suggestive of hyperadrenocorticism (HAC). Boston Terriers aren't as classically predisposed as some breeds like Poodles or Dachshunds, but these signs certainly warrant a thorough investigation.

When approaching a suspected case of HAC, my goal is to first confirm the diagnosis, and then, if positive, differentiate between pituitary-dependent hyperadrenocorticism (PDH) and adrenal-dependent hyperadrenocorticism (ADH). Here's the most sensitive diagnostic test sequence I would recommend:

Step 1: Initial Screening (Rule-Out Test)

The most sensitive screening test is the urine cortisol:creatinine ratio (UCCR).
* Why: It boasts a very high negative predictive value (sensitivity >90%). This means if the UCCR is normal, it is highly unlikely your patient has HAC, and you can confidently pursue other differentials. It's a non-invasive, relatively inexpensive first step.
Caveat: It has low specificity. Many non-adrenal illnesses and stressors can elevate the UCCR, leading to false positives. Therefore, a positive UCCR does not confirm* HAC, but it indicates the need for further testing.
* Procedure: Collect a urine sample at home by the owner on two consecutive mornings, ideally when the dog is relaxed, to minimize stress-induced elevations.

Step 2: Confirmatory Test (if UCCR is elevated or clinical suspicion remains high)

If the UCCR is elevated, or if your clinical suspicion is exceptionally high despite a normal UCCR (which is rare but possible), the low-dose dexamethasone suppression test (LDDST) is the gold standard for confirming HAC.
* Why: The LDDST is generally considered the most sensitive diagnostic test for HAC (sensitivity ~85-95%). It assesses the negative feedback loop on ACTH secretion.
* Procedure:
1. Collect a baseline serum cortisol sample (T0).
2. Administer dexamethasone at 0.01 mg/kg IV or IM.
3. Collect serum cortisol samples at 4 hours (T4) and 8 hours (T8) post-dexamethasone administration.
* Interpretation:
* Normal dogs will suppress cortisol levels below a specific threshold (typically <1.0 µg/dL or <30 nmol/L) at both T4 and T8.
* Dogs with HAC will fail to suppress cortisol levels at T8.
Suppression at T4 but escape at T8 can sometimes indicate PDH, but this is primarily a confirmatory* test, not a definitive differentiating one.

Step 3: Differentiation (if HAC is confirmed by LDDST)

Once HAC is confirmed, the next step is to determine if it's pituitary-dependent (PDH, ~80-85% of cases) or adrenal-dependent (ADH, ~15-20% of cases). This is critical for prognosis and treatment planning.
* Abdominal Ultrasound: This is my preferred first step for differentiation due to its ability to directly visualize the adrenal glands.
* Why: In PDH, both adrenal glands are typically symmetric and often mildly to moderately enlarged (though they can be normal). In ADH, one adrenal gland will be enlarged (due to a tumor) while the contralateral gland will be atrophied (due to chronic suppression of endogenous ACTH).
* Procedure: A thorough abdominal ultrasound by an experienced sonographer is crucial. Pay close attention to adrenal gland dimensions (width >7.4 mm in dogs is generally considered the upper normal limit, but asymmetry is key), architecture, and any evidence of vascular invasion if a mass is present.
* Endogenous ACTH Concentration: This blood test can be run concurrently with or after the ultrasound.
* Why: It directly measures the circulating ACTH level. In PDH, ACTH levels are typically normal to high (as the pituitary is overproducing ACTH). In ADH, ACTH levels are low to undetectable (as the adrenal tumor is autonomously producing cortisol, suppressing pituitary ACTH release).
* Caveat: This sample requires careful handling (EDTA plasma, immediate centrifugation, frozen shipment) to prevent degradation, so ensure your lab can accommodate this.
* High-Dose Dexamethasone Suppression Test (HDDST): While less commonly used as a primary differentiator than ultrasound or endogenous ACTH, it can still be helpful.
Why: The principle is that the higher dose of dexamethasone may suppress cortisol in dogs with PDH (as their pituitary is still somewhat responsive to feedback, just less so), but will not* suppress cortisol in dogs with ADH (as the adrenal tumor is autonomous).
* Procedure: Similar to LDDST, but with a higher dexamethasone dose (0.1 mg/kg IV or IM). Cortisol samples are taken at T0, T4, and T8.
* Interpretation: Suppression of cortisol to <50% of baseline or below the reference threshold (e.g., <1.4 µg/dL or <40 nmol/L) at either T4 or T8 indicates PDH. Lack of suppression indicates ADH.

Summary of Sequence:

Urine Cortisol:Creatinine Ratio (screening, rule-out)

If positive: Low-Dose Dexamethasone Suppression Test (confirmatory)

If positive: Abdominal Ultrasound (for adrenal visualization) and/or Endogenous ACTH Concentration (for differentiation)

This methodical approach ensures you are making an accurate diagnosis and subsequent treatment plan. I have high confidence in this sequence to effectively diagnose and differentiate hyperadrenocorticism in your patient.